DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more


Nutrilib.com
A comprihensive source of nutritional information

Perioperative Effect of Atenolol on Cytokine Profiles

Information source: Saini Foundation
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Surgery

Intervention: atenolol (Drug); placebo (Drug)

Phase: Phase 4

Status: Active, not recruiting

Sponsored by: Saini Foundation

Official(s) and/or principal investigator(s):
Vikas Saini, M.D., Principal Investigator, Affiliation: Dept Medicine, Cape Cod Hospital

Summary

Studies have shown that beta-blockers such as atenolol when given in the perioperative period reduce morbidity and mortality. One study showed that atenolol given just during the surgery period, seemed to improve outcomes up to 2 years later. This is hard to explain since beta-blockers act on the body by blocking the effects of adrenalin and thereby lowering heart rate and blood pressure.

This study is designed to find out if perioperative atenolol might exert its long term effects through an anti-inflammatory mechanism rather than by lowering heart rate and blood pressure. It is known that inflammation increases after surgery as part of the healing process. However, it is also becoming clear that low-grade chronic inflammation can also lead to long term adverse effects.

Clinical Details

Official title: The Effect of Perioperative Atenolol on Post-Operative Cytokines

Study design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment

Primary outcome: Postoperative levels of IL-6 and C-Reactive protein

Secondary outcome: IL-10, TNF-α

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- elective abdominal, orthopedic, or gynecologic surgery

- ability to give informed consent

- ability to tolerate beta-blocker therapy

- ability to comply with follow-up requirements

Exclusion Criteria:

- currently receiving beta-blocker therapy

- EKG documented 2nd or 3rd degree heart block

- EKG documented sinus bradycardia

- Serum creatinine > 2. 0

- current treatment asthma

- history of rheumatoid arthritis

- history of Crohn's disease

- history of lupus

- history of inflammatory cancer

Locations and Contacts

Cape Cod Hospital, Hyannis, Massachusetts 02601, United States
Additional Information

Starting date: November 2002
Ending date: September 2008
Last updated: June 13, 2008

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008